These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

427 related items for PubMed ID: 30569164

  • 1. DDAH2 alleviates myocardial fibrosis in diabetic cardiomyopathy through activation of the DDAH/ADMA/NOS/NO pathway in rats.
    Zhu ZD, Ye JM, Fu XM, Wang XC, Ye JY, Wu XR, Hua P, Liao YQ, Xuan W, Duan JL, Li WY, Fu H, Xia ZH, Zhang X.
    Int J Mol Med; 2019 Feb; 43(2):749-760. PubMed ID: 30569164
    [Abstract] [Full Text] [Related]

  • 2. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine.
    Feng M, Liu L, Guo Z, Xiong Y.
    Eur J Pharmacol; 2008 Apr 14; 584(1):49-56. PubMed ID: 18342305
    [Abstract] [Full Text] [Related]

  • 3. Protection of DDAH2 overexpression against homocysteine-induced impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells.
    Liu LH, Guo Z, Feng M, Wu ZZ, He ZM, Xiong Y.
    Cell Physiol Biochem; 2012 Apr 14; 30(6):1413-22. PubMed ID: 23171931
    [Abstract] [Full Text] [Related]

  • 4. Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2.
    Hasegawa K, Wakino S, Tatematsu S, Yoshioka K, Homma K, Sugano N, Kimoto M, Hayashi K, Itoh H.
    Circ Res; 2007 Jul 20; 101(2):e2-10. PubMed ID: 17601800
    [Abstract] [Full Text] [Related]

  • 5. Chronic renal impairment and DDAH2-1151 A/C polymorphism determine ADMA levels in type 2 diabetic subjects.
    Marra M, Marchegiani F, Ceriello A, Sirolla C, Boemi M, Franceschi C, Spazzafumo L, Testa I, Bonfigli AR, Cucchi M, Testa R.
    Nephrol Dial Transplant; 2013 Apr 20; 28(4):964-71. PubMed ID: 23129820
    [Abstract] [Full Text] [Related]

  • 6. Ex vivo gene transferring of human dimethylarginine dimethylaminohydrolase-2 improved endothelial dysfunction in diabetic rat aortas and high glucose-treated endothelial cells.
    Lu CW, Guo Z, Feng M, Wu ZZ, He ZM, Xiong Y.
    Atherosclerosis; 2010 Mar 20; 209(1):66-73. PubMed ID: 19775692
    [Abstract] [Full Text] [Related]

  • 7. Pyrrolidine dithiocarbamate ameliorates endothelial dysfunction in thoracic aorta of diabetic rats by preserving vascular DDAH activity.
    Lu CW, Lin Y, Lei YP, Wang L, He ZM, Xiong Y.
    PLoS One; 2017 Mar 20; 12(7):e0179908. PubMed ID: 28715444
    [Abstract] [Full Text] [Related]

  • 8. Dimethylarginine dimethylaminohydrolase-2 overexpression improves impaired nitric oxide synthesis of endothelial cells induced by glycated protein.
    Lu CW, Xiong Y, He P.
    Nitric Oxide; 2007 Feb 20; 16(1):94-103. PubMed ID: 16979918
    [Abstract] [Full Text] [Related]

  • 9. Protective effects of low-dose rosuvastatin on isoproterenol-induced chronic heart failure in rats by regulation of DDAH-ADMA-NO pathway.
    Zhou R, Ma P, Xiong A, Xu Y, Wang Y, Xu Q.
    Cardiovasc Ther; 2017 Apr 20; 35(2):. PubMed ID: 27957828
    [Abstract] [Full Text] [Related]

  • 10. Inhibitory effect of resveratrol derivative BTM-0512 on high glucose-induced cell senescence involves dimethylaminohydrolase/asymmetric dimethylarginine pathway.
    Yuan Q, Peng J, Liu SY, Wang CJ, Xiang DX, Xiong XM, Hu CP, Li YJ.
    Clin Exp Pharmacol Physiol; 2010 May 20; 37(5-6):630-5. PubMed ID: 20132235
    [Abstract] [Full Text] [Related]

  • 11. Asymmetric dimethyl L-arginine (ADMA) is a critical regulator of myocardial reperfusion injury.
    Stühlinger MC, Conci E, Haubner BJ, Stocker EM, Schwaighofer J, Cooke JP, Tsao PS, Pachinger O, Metzler B.
    Cardiovasc Res; 2007 Jul 15; 75(2):417-25. PubMed ID: 17559823
    [Abstract] [Full Text] [Related]

  • 12. Involvement of DDAH/ADMA/NOS pathway in nicotine-induced endothelial dysfunction.
    Jiang DJ, Jia SJ, Yan J, Zhou Z, Yuan Q, Li YJ.
    Biochem Biophys Res Commun; 2006 Oct 20; 349(2):683-93. PubMed ID: 16959216
    [Abstract] [Full Text] [Related]

  • 13. Enhancing kidney DDAH-1 expression by adenovirus delivery reduces ADMA and ameliorates diabetic nephropathy.
    Wetzel MD, Gao T, Stanley K, Cooper TK, Morris SM, Awad AS.
    Am J Physiol Renal Physiol; 2020 Feb 01; 318(2):F509-F517. PubMed ID: 31904280
    [Abstract] [Full Text] [Related]

  • 14. Effect of DDAH/ADMA/NOS regulation pathway on cavernae corporum cavernosorum rat penis of different age.
    Wang JH, Chen D, Zhang KQ, Zhang H, Fu Q.
    Andrologia; 2016 Apr 01; 48(3):262-7. PubMed ID: 26011316
    [Abstract] [Full Text] [Related]

  • 15. Involvement of increased endogenous asymmetric dimethylarginine in the hepatic endoplasmic reticulum stress of type 2 diabetic rats.
    Leng YP, Qiu N, Fang WJ, Zhang M, He ZM, Xiong Y.
    PLoS One; 2014 Apr 01; 9(2):e97125. PubMed ID: 24918756
    [Abstract] [Full Text] [Related]

  • 16. DDAH-2 alleviates contrast medium iopromide-induced acute kidney injury through nitric oxide synthase.
    Lin HH, Lee TS, Lin SJ, Yeh YC, Lu TM, Hsu CP.
    Clin Sci (Lond); 2019 Dec 12; 133(23):2361-2378. PubMed ID: 31763675
    [Abstract] [Full Text] [Related]

  • 17. Roles of accumulated endogenous nitric oxide synthase inhibitors, enhanced arginase activity, and attenuated nitric oxide synthase activity in endothelial cells for pulmonary hypertension in rats.
    Sasaki A, Doi S, Mizutani S, Azuma H.
    Am J Physiol Lung Cell Mol Physiol; 2007 Jun 12; 292(6):L1480-7. PubMed ID: 17322279
    [Abstract] [Full Text] [Related]

  • 18. Nephroprotective effects of nebivolol in 2K1C rats through regulation of the kidney ROS-ADMA-NO pathway.
    Wang Y, Niu M, Yin S, Zhang F, Shi R.
    Pharmacol Rep; 2018 Oct 12; 70(5):917-929. PubMed ID: 30099298
    [Abstract] [Full Text] [Related]

  • 19. Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension.
    Pullamsetti S, Kiss L, Ghofrani HA, Voswinckel R, Haredza P, Klepetko W, Aigner C, Fink L, Muyal JP, Weissmann N, Grimminger F, Seeger W, Schermuly RT.
    FASEB J; 2005 Jul 12; 19(9):1175-7. PubMed ID: 15827267
    [Abstract] [Full Text] [Related]

  • 20. Evidence for dysregulation of dimethylarginine dimethylaminohydrolase I in chronic hypoxia-induced pulmonary hypertension.
    Millatt LJ, Whitley GS, Li D, Leiper JM, Siragy HM, Carey RM, Johns RA.
    Circulation; 2003 Sep 23; 108(12):1493-8. PubMed ID: 12952847
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.